Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes

References

• AlfagemeI, de LucasP, AncocheaJ, et al. Nuevo estudio sobre la prevalencia de la EPOC en España: resumen del protocolo EPISCAN II, 10 años después de EPISCAN. Arch Bronconeumol. 2019;55(1):38–47. doi:10.1016/j.arbres.2018.05.01130612602
   PubMed Web of Science ®Google Scholar
• de Miguel DíezJ, GarcíaTG, MaestuLP. Comorbilidades de la EPOC. Arch Bronconeumol. 2010;46:20–25. doi:10.1016/S0300-2896(10)70058-2
   PubMedGoogle Scholar
• De la Iglesia MartínezF, Serrano ArrebaJ. Enfermedad obstructiva crónica (EPOC) y comorbilidades. Galicia Clínica. 2012;73(Supl 1):30. doi:10.22546/17/310
   Google Scholar
• YinH, YinS, LinQ, XuY, XuH, LiuT. Prevalence of comorbidities in chronic obstructive pulmonary disease patients. Medicine. 2017;96(19):e6836. doi:10.1097/MD.000000000000683628489768
   PubMed Web of Science ®Google Scholar
• DivoM, CoteC, de TorresJP, et al. Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2012;186(2):155–161.22561964
   PubMed Web of Science ®Google Scholar
• AlqahtaniF, WelleGA, ElsisyMF, et al. Incidence, Characteristics, and Outcomes of Acute Myocardial Infarction among Patients Admitted with Acute Exacerbation of Chronic Obstructive Lung Disease. COPD J Chronic Obstr Pulm Dis. 2015:15. doi:10.1080/15412555.2020.1757054.
   Web of Science ®Google Scholar
• de Miguel-díezJ, MorganJC, GarcíaJ-G. The association between COPD and heart failure risk: a review. International Journal of Chronic Obstructive Pulmonary Disease. 2013;8:305–312. doi:10.2147/COPD.S3123623847414
   PubMed Web of Science ®Google Scholar
• CorlateanuA, CovantevS, MathioudakisAG, BotnaruV, CazzolaM, SiafakasN. Chronic Obstructive Pulmonary Disease and Stroke. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2018;15(4):405–413. doi:10.1080/15412555.2018.146455129746193
   PubMed Web of Science ®Google Scholar
• ManninoDM, ThornD, SwensenA, HolguinF. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.0001240818579551
   PubMed Web of Science ®Google Scholar
• LinH, LuY, LinL, MengK, FanJ. Does chronic obstructive pulmonary disease relate to poor prognosis in patients with lung cancer? Medicine. 2019;98(11):e14837. doi:10.1097/MD.000000000001483730882673
   PubMed Web of Science ®Google Scholar
• GershonAS, MecredyGC, GuanJ, VictorJC, GoldsteinR, ToT. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J. 2015;45(1):51–59. doi:10.1183/09031936.0006141425142481
   PubMed Web of Science ®Google Scholar
• IncalziRA, FusoL, RosaMD, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10(12):2794–2800. doi:10.1183/09031936.97.101227949493663
   PubMed Web of Science ®Google Scholar
• MiravitllesM, Soler-CataluñaJJ, CalleM, et al. Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable. Arch Bronconeumol. 2017;53(6):324–335. doi:10.1016/j.arbres.2017.03.01828477954
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease [Internet]. 2019https://goldcopd.org. Accessed 109, 2020.
   Google Scholar
• Hernández VázquezJ, Ali GarcíaI, Jiménez-GarcíaR, et al. COPD phenotypes: differences in survival. Int J Chron Obstruct Pulmon Dis. 2018;13:2245–2251.30050297
   PubMed Web of Science ®Google Scholar
• AlmagroP, CabreraFJ, DiezJ, et al. Comorbidities and Short-term Prognosis in Patients Hospitalized for Acute Exacerbation of COPD: the EPOC en Servicios de Medicina Interna (ESMI) Study. Chest. 2012;142(5):1126–1133. doi:10.1378/chest.11-241323303399
   PubMed Web of Science ®Google Scholar
• NederJA, RochaA, AlencarMCN, et al. Current challenges in managing comorbid heart failure and COPD. Expert Rev Cardiovasc Ther. 2018;16(9):653–673. doi:10.1080/14779072.2018.151031930099925
   PubMed Web of Science ®Google Scholar
• StrußN, BauersachsJ, WelteT, HohlfeldJM. Linksherzfunktion bei COPD. Herz. 2019;44(6):477–482. doi:10.1007/s00059-019-4816-531187193
   PubMed Web of Science ®Google Scholar
• MorganAD, ZakeriR, QuintJK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524.29355081
   PubMed Web of Science ®Google Scholar
• OnishiK. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol. 2017;70(2):128–134.28325523
   PubMed Web of Science ®Google Scholar
• CavaillèsA, Brinchault-RabinG, DixmierA, et al. Comorbidities of COPD. Eur Respir Rev off J Eur Respir Soc. 2013;22(130):454–475. doi:10.1183/09059180.00008612
   PubMedGoogle Scholar
• KirkhamPA, BarnesPJ. Oxidative Stress in COPD. CHEST. 2013;144(1):266–273. doi:10.1378/chest.12-266423880677
   PubMed Web of Science ®Google Scholar
• FedeliU, De GiorgiA, GennaroN, et al. Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy. <![CDATA[International Journal of Chronic Obstructive Pulmonary Disease]]>. 2017;12:443–450. doi:10.2147/COPD.S11939028184156
   PubMedGoogle Scholar
• TrudzinskiFC, AlqudrahM, OmlorA, et al. Consequences of chronic kidney disease in chronic obstructive pulmonary disease. Respiratory Research. 2019;20(1):151. doi:10.1186/s12931-019-1107-x31299972
   PubMed Web of Science ®Google Scholar
• LimJU, YeoCD, RheeCK, et al. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients. <![CDATA[International Journal of Chronic Obstructive Pulmonary Disease]]>. 2019;14:929–938. doi:10.2147/COPD.S19024431118602
   PubMed Web of Science ®Google Scholar
• GaoY, GuanW, LiuQ, et al. Impact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studies. Respirology. 2016;21(2):269–279. doi:10.1111/resp.1266126567533
   PubMed Web of Science ®Google Scholar
• WangW, DouS, DongW, et al. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity. <![CDATA[International Journal of Chronic Obstructive Pulmonary Disease]]>. 2018;13:3767–3776. doi:10.2147/COPD.S16804830538439
   PubMed Web of Science ®Google Scholar
• YiY-S, BanWH, SohngK-Y. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer. BMC Cancer. 2018;18(1):1053. doi:10.1186/s12885-018-4976-330373585
   PubMed Web of Science ®Google Scholar
• MediaAS, PerssonM, TajhiziN, WeinreichUM. Chronic obstructive pulmonary disease and comorbidities’ influence on mortality in non-small cell lung cancer patients. Acta Oncol Stockh Swed. 2019;58(8):1102–1106. doi:10.1080/0284186X.2019.1612942
   PubMed Web of Science ®Google Scholar
• SeijoLM, ZuluetaJJ. Understanding the Links Between Lung Cancer, COPD, and Emphysema: A Key to More Effective Treatment and Screening. Oncol Williston Park N. 2017;31(2):93–102.
   PubMed Web of Science ®Google Scholar
• García-SanzM-T, Cánive-GómezJ-C, Senín-RialL, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(3):636–645. doi:10.21037/jtd.2017.03.3428449471
   PubMed Web of Science ®Google Scholar
• XieF, XieL. COPD and the risk of mild cognitive impairment and dementia: a cohort study based on the Chinese Longitudinal Health Longevity Survey. <![CDATA[International Journal of Chronic Obstructive Pulmonary Disease]]>. 2019;14:403–408. doi:10.2147/COPD.S19427730863040
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJ, GómezFP, BenetM, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430–437. doi:10.1136/thx.2010.15448421177668
   PubMed Web of Science ®Google Scholar
• AgustiA, CalverleyPM, CelliB, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122.20831787
   PubMed Web of Science ®Google Scholar